Abdel Ghaffar highlights impact of regional conflicts on health services
Egypt's Deputy Prime Minister for Human Development and Minister of Health and Population of Egypt, Khaled Abdel Ghaffar, participated on Tuesday in the 71st session of the World Health Organization Regional Committee for the Eastern Mediterranean Region, held in Qatar under the slogan "Health without Borders."
In his speech, the minister stressed that the current explosive conflicts in Palestine, Sudan and Lebanon have seriously disrupted health systems and deteriorated health outcomes for countless individuals, affirming that Egypt stands in solidarity with its brothers in Palestine, Sudan and Lebanon, providing humanitarian support and health assistance to alleviate their suffering. Abdel Ghaffar said that one of the biggest challenges facing the formulation of health policy in the Eastern Mediterranean Region is the diversity that characterizes the region, from large disparities in income, social conditions and access to technology, which in turn leads to large disparities in health. He explained that no single solution or policy can effectively meet the unique needs of each country, so this diversity must be considered a distinctive feature of the region and benefited from by taking advantage of the best practices and capabilities that each country has. The minister added that the WHO's 14th General Programme of Work provides an excellent basis for this approach, as it emphasizes the importance of effective partnerships with countries to maximize positive impacts on public health, and calls for amending WHO's operational strategies to enhance effectiveness at the country level. The Deputy Prime Minister stressed that political commitment to universal health coverage, along with investment in strong health systems, are key elements for achieving long-term stability, security and prosperity in the region. He pointed out that the Egyptian government is working tirelessly to expand the scope of manufacturing medicines and vaccines to meet local needs and support other countries, noting that Egypt was selected in 2022 as one of the countries eligible to receive mRNA technology for manufacturing vaccines through the WHO Global Initiative and working in parallel to enhance international cooperation through the Accelerating Vaccine Manufacturing Mechanism in Africa (AVMA). Egypt is also participating in the ongoing negotiations in the Intergovernmental Negotiating Body on the Pandemic Treaty. Nevertheless, Abdel Ghaffar announced Egypt's welcome of the Political Declaration on Antimicrobial Resistance, adopted by the United Nations General Assembly at its 79th session, which is a strong affirmation of our collective commitment. He further called on all countries of the Eastern Mediterranean region to participate in the second edition of the World Conference on Population, Health and Human Development, which will be held from 20 to 25 October in Cairo, under the patronage of Egypt's President Abdel Fattah Al-Sisi.
Hashtags
- Health#Egypt,14thGeneralProgrammeofWork,Egyptian,WHOGlobalInitiative,AcceleratingVaccineManufacturingMechanisminAfrica,AVMA,PandemicTreaty,PoliticalDeclarationonAntimicrobialResistance,EasternMediterranean,WorldConferenceonPopulation,HealthandHumanDevelopment,AbdelGhaffar,KhaledAbdelGhaffar,AbdelFattahAl-Sisi,WHO,HealthandPopulationofEgypt,WorldHealthOrganization,RegionalCommittee,IntergovernmentalNegotiatingBody,UnitedNationsGeneralAssembly
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
a day ago
- Daily News Egypt
Egypt, US partner to launch global pharmaceutical manufacturing, export venture
Egypt has signed a major joint venture agreement with US-based Dawah Pharma to manufacture and export pharmaceutical products and nutritional supplements to global markets, with a strategic focus on North America and Europe. The deal marks a significant milestone in Egypt's push to expand its pharmaceutical exports and attract foreign investment to its health sector. Prime Minister Mostafa Madbouly witnessed the signing ceremony, which took place in the presence of Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Minister of Public Enterprise Sector Mohamed El-Shimy, Head of the Egyptian Drug Authority Ali El-Ghamrawy, and Hisham Setit, Head of the Unified Procurement Authority for Medical Supplies and Technology. The agreement was signed by Ashraf El-Khouly, Executive Managing Director of the Egyptian Holding Company for Pharmaceuticals—affiliated with the Ministry of Public Enterprise Sector—and Hossam Abdel Maksoud, Chairman of Dawah Pharma. Prime Minister Madbouly said the agreement reflects Egypt's broader strategy to enhance national industries, with the pharmaceutical sector identified as a key priority. He described the partnership as a strong vote of confidence in the quality and potential of Egyptian manufacturing, particularly in the medical field. Minister El-Shimy emphasized that the partnership follows major investments to modernize the holding company's infrastructure, upgrade production lines, and align operations with international Good Manufacturing Practices (GMP). He described the venture as a pivotal step in Egypt's plan to boost pharmaceutical exports, strengthen international collaboration, and increase foreign direct investment. Under the agreement, the new joint venture will manufacture and export a wide range of products including ampoules, nutritional supplements, sterile injections, ophthalmic preparations, and over-the-counter (OTC) medications. The first phase will focus on exporting six pre-approved dietary supplements to the US market—an unprecedented move for the Holding Company for Pharmaceuticals, after meeting all relevant international regulatory and quality benchmarks. The venture will leverage state-of-the-art manufacturing technologies for a diverse range of dosage forms including syrups, tablets, ampoules, pre-filled syringes, and transdermal patches. This is expected to accelerate global market entry for Egyptian-made products and support long-term growth for the company and its subsidiaries. El-Shimy affirmed that the new company will comply with the most stringent international regulations, particularly those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the competitiveness of Egyptian products in North America, Europe, and emerging markets in Africa and Asia. As per the terms of the agreement, the Egyptian Holding Company for Pharmaceuticals will hold a 40% stake in the joint venture, while Dawah Pharma will own 60%. The partnership will also spearhead efforts to open new international markets for Egyptian pharmaceutical exports, solidifying Egypt's position as a regional hub for high-quality medical manufacturing.
Egypt Today
2 days ago
- Egypt Today
Egypt & U.S. Form Joint Venture to Boost Global Pharmaceutical Exports
CAIRO - 28 May 2025: The Holding Company for Pharmaceuticals, Chemicals, and Medical Supplies has entered into a strategic joint venture with American pharmaceutical firm Dawah Pharma. This partnership marks a significant step in Egypt's push to expand its pharmaceutical footprint globally, with plans to manufacture and export a broad range of pharmaceutical products and dietary supplements to international markets. Minister of Public Business Sector Mohamed Shimi announced that the new venture will produce a diverse portfolio of products, including ampoules, sterile injections, ophthalmic solutions, over-the-counter (OTC) medications, and dietary supplements. The joint venture structure grants the Egyptian side a 40 percent share, while Dawah Pharma holds a 60% majority stake. The newly formed company will focus primarily on exporting its products and opening new channels in global markets. In a milestone move, the partnership's first phase will see the manufacture and export of six specific dietary supplements to the United States—marking the first time in the Holding Company's history to achieve such a feat after meeting rigorous international standards and requirements. The agreement also leverages advanced pharmaceutical manufacturing technologies, including the production of syrups, tablets, ampoules, pre-filled syringes, and transdermal patches. These innovations are expected to significantly accelerate product deployment and support long-term growth for the Holding Company and its subsidiaries. Shimi stressed that the new company will strictly follow international regulatory standards, particularly those enforced by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Adhering to these benchmarks will boost the global competitiveness of Egyptian pharmaceuticals—not only in the high-demand markets of Europe and North America but also in emerging markets across Africa and Asia.
CairoScene
2 days ago
- CairoScene
Egyptian Medical Mission Delivers Critical Care to Hajj Pilgrims
Egyptian clinics are operating 24/7 in Makkah and Madinah, offering care to both Egyptian and non-Egyptian pilgrims alike. May 28, 2025 The Egyptian medical mission for Hajj announced that it has handled several critical medical cases among pilgrims visiting its clinics at hotels and other key points across Makkah and Madinah, including patients requiring kidney dialysis and chemotherapy. One individual was transferred for dialysis treatment, while another was referred for a chemotherapy session. These interventions fall under a comprehensive medical framework designed to provide urgent and specialized care to Egyptian pilgrims during the Hajj season. The mission confirmed that full coordination is ongoing with Saudi hospitals to maintain a high standard of medical service. Transferred patients are being monitored on a daily basis to ensure their health remains stable, allowing them to safely continue their pilgrimage. Pilgrims have been advised to adhere to all health guidelines and to seek immediate medical attention at the clinics should they experience any symptoms. The clinics remain open around the clock and offer services to both Egyptian and non-Egyptian pilgrims without discrimination.
